Used as a key intermediate in the synthesis of pharmaceutical compounds targeting inflammatory diseases and certain cancers. Its structure supports the development of selective kinase inhibitors, particularly in modulating signaling pathways involved in cell proliferation. Commonly employed in research settings for designing analogs with improved metabolic stability and binding affinity. Also utilized in the preparation of bioactive molecules showing potential in neurodegenerative disorder studies due to its ability to cross the blood-brain barrier. Shows promise in medicinal chemistry for optimizing lead compounds in drug discovery programs.